| Unique ID issued by UMIN | UMIN000057213 |
|---|---|
| Receipt number | R000065390 |
| Scientific Title | Clinical study on the effects of a nutritional supplement intake on nutritional status and appetite. |
| Date of disclosure of the study information | 2025/03/05 |
| Last modified on | 2025/09/03 11:34:51 |
Clinical study on the effects of a nutritional supplement intake on nutritional status and appetite.
Clinical study on the effects of a nutritional supplement intake on nutritional status and appetite.
Clinical study on the effects of a nutritional supplement intake on nutritional status and appetite.
Clinical study on the effects of a nutritional supplement intake on nutritional status and appetite.
| Japan |
Under-nutritional condition
| Not applicable |
Others
NO
To evaluate the effect of a nutritional supplement on the nutritional status and appetite of the hospitalized patients.
Efficacy
Anthropometry(weight, body composition), blood tests (Alb, glucose metabolism, etc.), hospital meal eating rate, appetite survey (questionnaire form)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Food |
Taking orally one pack of nutritional supplement per day for 12 weeks
| 65 | years-old | <= |
| Not applicable |
Male and Female
(1) Patients who are 65 years of age or older
(2) Patients who are hospitalized at Tsurukawa Sanatorium Hospital
(3) Patients who are able to eat and drink orally
(4) Patients who obtain their daily required energy from hospital meals must meet either condition 1 or condition 2 below
Condition 1: Patients whose stable intake are more than 70% but less than 80% of their hospital meal
Condition 2: Patients whose stable intake are more than 80% of their hospital meal and their BMI are less than 21.5
(5) Patients who have blood tests conducted once every three months
(1) Patients receiving tube feeding or intravenous nutrition
(2) Patients with severe edema, ascites, or pleural effusion
(3) Patients who have allergic symptoms due to intake of milk or soy-derived ingredients
(4) Persons who are participating in other clinical trials or who plan to participate in other clinical trials during the study period
(5) Patients who are judged to be unsuitable as subjects by the investigator or subinvestigator based on the subject background, symptoms, clinical laboratory values, etc.
30
| 1st name | Shigemitsu |
| Middle name | |
| Last name | Hayashi |
IMS Group Medical Corporation Meirikai
Tsurukawa Sanatorium Hospital
195-0051
197 Shinkoji-machi, Machida-city, Tokyo
042-735-2222
hayashi.shigemitsu@ims.gr.jp
| 1st name | Ayako |
| Middle name | |
| Last name | Ito |
Morinaga Milk Industry Co., Ltd.
Health Care & Nutritional Science Institute, R&D Division
252-8583
1-83, 5-Chome, Higashihara, Zama-City, Kanagawa-Pref, Japan
046-252-3057
a-asao@morinagamilk.co.jp
IMS Group Medical Corporation Meirikai Tsurukawa Sanatorium Hospital
Morinaga Milk Industry Co., Ltd.
Profit organization
Medical Corporation Meirikai Tsurukawa Sanatorium Hospital Ethics committee
197 Shinkoji-machi, Machida-city, Tokyo
042-735-2222
eiyouka3710@ims.gr.jp
NO
| 2025 | Year | 03 | Month | 05 | Day |
Unpublished
Enrolling by invitation
| 2024 | Year | 11 | Month | 13 | Day |
| 2024 | Year | 11 | Month | 15 | Day |
| 2025 | Year | 03 | Month | 06 | Day |
| 2026 | Year | 02 | Month | 28 | Day |
| 2025 | Year | 03 | Month | 05 | Day |
| 2025 | Year | 09 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065390